Bright Peak Therapeutics

Bright Peak Therapeutics develops novel cytokines using its EDC platform to treat cancer and autoimmune diseases with high precision and efficacy.
Domain
Healthcare
Status
Current Private Investment
Stage of Initial Investment
Series B
Initial Investment Year
2021
Bright Peak Portco Hover Image